November 24, 2014

Biotechnology, Food & Drug Administration FDA News

Syndicate content

The National Law Review includes articles impacting the biotech and cleantech fields addressing: licensing and patent issues, intellectual property due diligence, litigation and tax. Content is also included addressing: greenhouse gas (GHG) regulation; mandated emissions reduction legislation; NEPA and CEQA claims, common law nuisance litigation; acquiring and selling emission offset and emission reduction credits and acid rain allowances under the United States Clean Air Act, SCAQMD RECLAIM and other air credit programs.

Date Title Organization
21
Nov
Purdue Pharma L.P. v. Depomed, Inc., Denying Motion to Seal and Joint Motion for Protective Order IPR2014-00377; IPR2014-00378; IPR2014-00379 Drinker Biddle & Reath LLP
21
Nov
Faulty Damages Model Leads to Partial Decertification in California Sheppard, Mullin, Richter & Hampton LLP
21
Nov
The German Supreme Administrative Court Confirms That E-Cigarettes Are Not Medicines Or Medical Devices Covington & Burling LLP
21
Nov
FERC Orders ISOs (Independent System Operators) to Address Fuel Assurance Issues 149 FERC ¶ 61,145 (2014) Bracewell & Giuliani LLP
20
Nov
D.C. Circuit Upholds Contraceptive Coverage Mandate Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
20
Nov
Africa: Realizing the Potential to Become the Breadbasket of the World Greenberg Traurig, LLP
20
Nov
Antares Pharma Bolsters the “Original Patent” Rule for Reissued Patents Michael Best & Friedrich LLP
20
Nov
Health Resources and Services Administration (HRSA) Withdraws 340B Program Proposed Rule McDermott Will & Emery
20
Nov
Recent Trends in Medical Device Patent Litigation at the ITC: Part 3 Covington & Burling LLP
20
Nov
Vascular Solutions Inc. and its CEO Face Criminal Charges for Selling Unapproved Medical Devices Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
20
Nov
A Report from the “Biosimilars and Biotech: MENA Conference” in Istanbul, Turkey: Part 1 Michael Best & Friedrich LLP
19
Nov
CPSC Focusing on Three Areas for Reduction of CPSIA Testing Burdens Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
19
Nov
Comments Sought by December 19th on the FDA's Proposed Criteria for "First Generic" Applications Katten Muchin Rosenman LLP
19
Nov
The 340B Mega-Reg is Dead re: Drug Discount Program Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
19
Nov
Mirror, Mirror on Your App…The Cosmetics Industry Embraces Digital Covington & Burling LLP
18
Nov
When You Fish Upon A Star: Yates v. United States Bracewell & Giuliani LLP
18
Nov
Telehealth/Telemedicine: An Opportunity for Physicians and Providers to Add a New Line of Service McBrayer, McGinnis, Leslie and Kirkland, PLLC
17
Nov
Health Insurer Antitrust Claim Against Drug Company Remanded to State Court Dickinson Wright PLLC
15
Nov
Potential Minimum Wage Exposure for California Employees Paid on Commission/Piece-Rate Basis Morgan, Lewis & Bockius LLP
14
Nov
A Taste of Things to Come? Whole Foods Feels Sting of “Non-GMO” Litigation Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Advertisement

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS